Literature DB >> 30940932

T cell-mediated immunity to malaria.

Noah S Butler1,2, John T Harty3,4,5, Samarchith P Kurup1.   

Abstract

Immunity to malaria has been linked to the availability and function of helper CD4+ T cells, cytotoxic CD8+ T cells and γδ T cells that can respond to both the asymptomatic liver stage and the symptomatic blood stage of Plasmodium sp. infection. These T cell responses are also thought to be modulated by regulatory T cells. However, the precise mechanisms governing the development and function of Plasmodium-specific T cells and their capacity to form tissue-resident and long-lived memory populations are less well understood. The field has arrived at a point where the push for vaccines that exploit T cell-mediated immunity to malaria has made it imperative to define and reconcile the mechanisms that regulate the development and functions of Plasmodium-specific T cells. Here, we review our current understanding of the mechanisms by which T cell subsets orchestrate host resistance to Plasmodium infection on the basis of observational and mechanistic studies in humans, non-human primates and rodent models. We also examine the potential of new experimental strategies and human infection systems to inform a new generation of approaches to harness T cell responses against malaria.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30940932      PMCID: PMC6599480          DOI: 10.1038/s41577-019-0158-z

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  245 in total

1.  Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

Authors:  Mahamadou S Sissoko; Sara A Healy; Abdoulaye Katile; Freda Omaswa; Irfan Zaidi; Erin E Gabriel; Bourama Kamate; Yacouba Samake; Merepen A Guindo; Amagana Dolo; Amadou Niangaly; Karamoko Niaré; Amatigue Zeguime; Kourane Sissoko; Hama Diallo; Ismaila Thera; Kelly Ding; Michael P Fay; Elise M O'Connell; Thomas B Nutman; Sharon Wong-Madden; Tooba Murshedkar; Adam J Ruben; Minglin Li; Yonas Abebe; Anita Manoj; Anusha Gunasekera; Sumana Chakravarty; B Kim Lee Sim; Peter F Billingsley; Eric R James; Michael Walther; Thomas L Richie; Stephen L Hoffman; Ogobara Doumbo; Patrick E Duffy
Journal:  Lancet Infect Dis       Date:  2017-02-16       Impact factor: 25.071

2.  Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.

Authors:  Andrew S Ishizuka; Kirsten E Lyke; Adam DeZure; Andrea A Berry; Thomas L Richie; Floreliz H Mendoza; Mary E Enama; Ingelise J Gordon; Lee-Jah Chang; Uzma N Sarwar; Kathryn L Zephir; LaSonji A Holman; Eric R James; Peter F Billingsley; Anusha Gunasekera; Sumana Chakravarty; Anita Manoj; MingLin Li; Adam J Ruben; Tao Li; Abraham G Eappen; Richard E Stafford; Natasha K C; Tooba Murshedkar; Hope DeCederfelt; Sarah H Plummer; Cynthia S Hendel; Laura Novik; Pamela J M Costner; Jamie G Saunders; Matthew B Laurens; Christopher V Plowe; Barbara Flynn; William R Whalen; J P Todd; Jay Noor; Srinivas Rao; Kailan Sierra-Davidson; Geoffrey M Lynn; Judith E Epstein; Margaret A Kemp; Gary A Fahle; Sebastian A Mikolajczak; Matthew Fishbaugher; Brandon K Sack; Stefan H I Kappe; Silas A Davidson; Lindsey S Garver; Niklas K Björkström; Martha C Nason; Barney S Graham; Mario Roederer; B Kim Lee Sim; Stephen L Hoffman; Julie E Ledgerwood; Robert A Seder
Journal:  Nat Med       Date:  2016-05-09       Impact factor: 53.440

Review 3.  Recent Insights into CD4+ Th Cell Differentiation in Malaria.

Authors:  Megan S F Soon; Ashraful Haque
Journal:  J Immunol       Date:  2018-03-15       Impact factor: 5.422

4.  Protection against a malaria challenge by sporozoite inoculation.

Authors:  Meta Roestenberg; Matthew McCall; Joost Hopman; Jorien Wiersma; Adrian J F Luty; Geert Jan van Gemert; Marga van de Vegte-Bolmer; Ben van Schaijk; Karina Teelen; Theo Arens; Lopke Spaarman; Quirijn de Mast; Will Roeffen; Georges Snounou; Laurent Rénia; Andre van der Ven; Cornelus C Hermsen; Robert Sauerwein
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

5.  Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.

Authors:  Robert A Seder; Lee-Jah Chang; Mary E Enama; Kathryn L Zephir; Uzma N Sarwar; Ingelise J Gordon; LaSonji A Holman; Eric R James; Peter F Billingsley; Anusha Gunasekera; Adam Richman; Sumana Chakravarty; Anita Manoj; Soundarapandian Velmurugan; MingLin Li; Adam J Ruben; Tao Li; Abraham G Eappen; Richard E Stafford; Sarah H Plummer; Cynthia S Hendel; Laura Novik; Pamela J M Costner; Floreliz H Mendoza; Jamie G Saunders; Martha C Nason; Jason H Richardson; Jittawadee Murphy; Silas A Davidson; Thomas L Richie; Martha Sedegah; Awalludin Sutamihardja; Gary A Fahle; Kirsten E Lyke; Matthew B Laurens; Mario Roederer; Kavita Tewari; Judith E Epstein; B Kim Lee Sim; Julie E Ledgerwood; Barney S Graham; Stephen L Hoffman
Journal:  Science       Date:  2013-08-08       Impact factor: 47.728

6.  Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.

Authors:  Jason A Regules; Susan B Cicatelli; Jason W Bennett; Kristopher M Paolino; Patrick S Twomey; James E Moon; April K Kathcart; Kevin D Hauns; Jack L Komisar; Aziz N Qabar; Silas A Davidson; Sheetij Dutta; Matthew E Griffith; Charles D Magee; Mariusz Wojnarski; Jeffrey R Livezey; Adrian T Kress; Paige E Waterman; Erik Jongert; Ulrike Wille-Reece; Wayne Volkmuth; Daniel Emerling; William H Robinson; Marc Lievens; Danielle Morelle; Cynthia K Lee; Bebi Yassin-Rajkumar; Richard Weltzin; Joe Cohen; Robert M Paris; Norman C Waters; Ashley J Birkett; David C Kaslow; W Ripley Ballou; Christian F Ockenhouse; Johan Vekemans
Journal:  J Infect Dis       Date:  2016-06-13       Impact factor: 5.226

Review 7.  Immune checkpoint blockade in infectious diseases.

Authors:  Michelle N Wykes; Sharon R Lewin
Journal:  Nat Rev Immunol       Date:  2017-10-09       Impact factor: 53.106

8.  Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.

Authors:  Benjamin Mordmüller; Güzin Surat; Heimo Lagler; Sumana Chakravarty; Andrew S Ishizuka; Albert Lalremruata; Markus Gmeiner; Joseph J Campo; Meral Esen; Adam J Ruben; Jana Held; Carlos Lamsfus Calle; Juliana B Mengue; Tamirat Gebru; Javier Ibáñez; Mihály Sulyok; Eric R James; Peter F Billingsley; K C Natasha; Anita Manoj; Tooba Murshedkar; Anusha Gunasekera; Abraham G Eappen; Tao Li; Richard E Stafford; Minglin Li; Phil L Felgner; Robert A Seder; Thomas L Richie; B Kim Lee Sim; Stephen L Hoffman; Peter G Kremsner
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962

9.  Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.

Authors:  Michael T White; Robert Verity; Jamie T Griffin; Kwaku Poku Asante; Seth Owusu-Agyei; Brian Greenwood; Chris Drakeley; Samwel Gesase; John Lusingu; Daniel Ansong; Samuel Adjei; Tsiri Agbenyega; Bernhards Ogutu; Lucas Otieno; Walter Otieno; Selidji T Agnandji; Bertrand Lell; Peter Kremsner; Irving Hoffman; Francis Martinson; Portia Kamthunzu; Halidou Tinto; Innocent Valea; Hermann Sorgho; Martina Oneko; Kephas Otieno; Mary J Hamel; Nahya Salim; Ali Mtoro; Salim Abdulla; Pedro Aide; Jahit Sacarlal; John J Aponte; Patricia Njuguna; Kevin Marsh; Philip Bejon; Eleanor M Riley; Azra C Ghani
Journal:  Lancet Infect Dis       Date:  2015-09-02       Impact factor: 25.071

10.  Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.

Authors:  Katie J Ewer; Geraldine A O'Hara; Christopher J A Duncan; Katharine A Collins; Susanne H Sheehy; Arturo Reyes-Sandoval; Anna L Goodman; Nick J Edwards; Sean C Elias; Fenella D Halstead; Rhea J Longley; Rosalind Rowland; Ian D Poulton; Simon J Draper; Andrew M Blagborough; Eleanor Berrie; Sarah Moyle; Nicola Williams; Loredana Siani; Antonella Folgori; Stefano Colloca; Robert E Sinden; Alison M Lawrie; Riccardo Cortese; Sarah C Gilbert; Alfredo Nicosia; Adrian V S Hill
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  47 in total

1.  Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation.

Authors:  Ana Carolina Moreira Souza; Andrea Grabe-Guimarães; Jader Dos Santos Cruz; Artur Santos-Miranda; Charlotte Farah; Liliam Teixeira Oliveira; Alexandre Lucas; Franck Aimond; Pierre Sicard; Vanessa Carla Furtado Mosqueira; Sylvain Richard
Journal:  Br J Pharmacol       Date:  2020-08-24       Impact factor: 8.739

Review 2.  You Shall Not Pass: Memory CD8 T Cells in Liver-Stage Malaria.

Authors:  Mitchell N Lefebvre; John T Harty
Journal:  Trends Parasitol       Date:  2019-12-13

3.  Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity.

Authors:  Vincent van Unen; Mikhael D Manurung; Koen A Stam; Sanne E de Jong; Jelle J Goeman; Simon P Jochems; Thomas Höllt; Nicola Pezzotti; Yoanne D Mouwenda; Madeleine Eunice Betouke Ongwe; Freia-Raphaella Lorenz; Yvonne C M Kruize; Shohreh Azimi; Marion H König; Anna Vilanova; Elmar Eisemann; Boudewijn P F Lelieveldt; Meta Roestenberg; B Kim Lee Sim; Marcel J T Reinders; Rolf Fendel; Stephen L Hoffman; Peter G Kremsner; Frits Koning; Benjamin Mordmüller; Bertrand Lell; Maria Yazdanbakhsh
Journal:  Nat Immunol       Date:  2021-04-22       Impact factor: 25.606

Review 4.  Liver-resident memory T cells: life in lockdown.

Authors:  Laura J Pallett; Mala K Maini
Journal:  Semin Immunopathol       Date:  2022-04-28       Impact factor: 9.623

5.  Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites.

Authors:  Mitchell N Lefebvre; Lisa L Drewry; Lecia L Pewe; Lisa S Hancox; Arturo Reyes-Sandoval; John T Harty
Journal:  J Immunol       Date:  2021-10-29       Impact factor: 5.422

6.  Chemoprophylaxis under sporozoites-lumefantrine (CPS-LMF) immunization induce protective immune responses against Plasmodium yoelii sporozoites infection in mice.

Authors:  Arif Jamal Siddiqui; Jyoti Bhardwaj; Walid Sabri Hamadou; Manish Goyal; Syed Amir Ashraf; Sadaf Jahan; Arshad Jamal; Pankaj Sharma; Manojkumar Sachidanandan; Riadh Badraoui; Mohd Adnan
Journal:  3 Biotech       Date:  2021-10-19       Impact factor: 2.406

7.  New Insights into Antimalarial Chemopreventive Activity of Antifolates.

Authors:  Chatpong Pethrak; Navaporn Posayapisit; Jutharat Pengon; Nattida Suwanakitti; Atiporn Saeung; Molnipha Shorum; Kittipat Aupalee; Kritsana Taai; Yongyuth Yuthavong; Sumalee Kamchonwongpaisan; Natapong Jupatanakul
Journal:  Antimicrob Agents Chemother       Date:  2021-12-20       Impact factor: 5.938

Review 8.  Antibodies against Plasmodium falciparum malaria at the molecular level.

Authors:  Jean-Philippe Julien; Hedda Wardemann
Journal:  Nat Rev Immunol       Date:  2019-08-28       Impact factor: 53.106

9.  Impact of Dietary Protein Restriction on the Immunogenicity and Efficacy of Whole-Sporozoite Malaria Vaccination.

Authors:  Helena Nunes-Cabaço; Diana Moita; Catarina Rôla; António M Mendes; Miguel Prudêncio
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

Review 10.  Mesenchymal Stem Cells: A Novel Therapeutic Approach to Enhance Protective Immunomodulation and Erythropoietic Recovery in Malaria.

Authors:  Meenu Kalkal; Mrinalini Tiwari; Reva S Thakur; Vikky Awasthi; Veena Pande; Debprasad Chattopadhyay; Jyoti Das
Journal:  Stem Cell Rev Rep       Date:  2021-06-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.